- Home
- COAG vs LADR Comparison
COAG vs LADR Comparison
Compare COAG & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COAG | LADR |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2026 | 2013 |
Fundamental Metrics
Financial Performance| Metric | COAG | LADR |
|---|---|---|
| Price | $46.11 | $9.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.25 |
| AVG Volume (30 Days) | 292.5K | ★ 1.1M |
| Earning Date | N/A | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $31.66 |
| Revenue Next Year | N/A | $16.92 |
| P/E Ratio | ★ N/A | $477.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.47 | $9.43 |
| 52 Week High | $52.15 | $11.92 |
Technical Indicators
Market Signals| Indicator | COAG | LADR |
|---|---|---|
| Relative Strength Index (RSI) | 64.50 | 43.08 |
| Support Level | $28.51 | $9.63 |
| Resistance Level | $52.15 | $10.42 |
| Average True Range (ATR) | 4.28 | 0.21 |
| MACD | 0.74 | -0.02 |
| Stochastic Oscillator | 75.47 | 29.78 |
Price Performance
Historical ComparisonAbout COAG Hemab Therapeutics Holdings Inc. Common Stock
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.